Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C
- PMID: 24356811
- DOI: 10.1007/s00535-013-0926-7
Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C
Comment on
-
Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1-infected patients in Japan: the DRAGON study.J Gastroenterol. 2014 Jan;49(1):138-47. doi: 10.1007/s00535-013-0875-1. Epub 2013 Sep 5. J Gastroenterol. 2014. PMID: 24005956 Free PMC article. Clinical Trial.
Similar articles
-
Controlling hepatitis C with simeprevir.Lancet Infect Dis. 2015 Jan;15(1):2-4. doi: 10.1016/S1473-3099(14)71048-5. Epub 2014 Dec 5. Lancet Infect Dis. 2015. PMID: 25482331 No abstract available.
-
[Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C].Ter Arkh. 2014;86(11):105-14. Ter Arkh. 2014. PMID: 25715498 Russian.
-
Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study.Clin Infect Dis. 2014 Dec 1;59(11):1579-87. doi: 10.1093/cid/ciu675. Epub 2014 Sep 5. Clin Infect Dis. 2014. PMID: 25192745 Clinical Trial.
-
Simeprevir for the treatment of chronic hepatitis C.Expert Opin Pharmacother. 2013 Dec;14(18):2581-9. doi: 10.1517/14656566.2013.850074. Epub 2013 Oct 19. Expert Opin Pharmacother. 2013. PMID: 24138198 Review.
-
Simeprevir for the treatment of chronic hepatitis C genotype 1 infection.Expert Rev Anti Infect Ther. 2014 Aug;12(8):909-17. doi: 10.1586/14787210.2014.925800. Epub 2014 Jun 2. Expert Rev Anti Infect Ther. 2014. PMID: 24882512 Review.
Cited by
-
New treatments for genotype 1 chronic hepatitis C - focus on simeprevir.Ther Clin Risk Manag. 2014 May 24;10:387-94. doi: 10.2147/TCRM.S50170. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 24920913 Free PMC article. Review.
-
Structure-activity relationship studies on quinoxalin-2(1H)-one derivatives containing thiazol-2-amine against hepatitis C virus leading to the discovery of BH6870.Mol Divers. 2015 Nov;19(4):829-53. doi: 10.1007/s11030-015-9610-6. Epub 2015 Jul 24. Mol Divers. 2015. PMID: 26205408
-
Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia.Case Rep Hematol. 2016;2016:7635128. doi: 10.1155/2016/7635128. Epub 2016 Mar 2. Case Rep Hematol. 2016. PMID: 27042368 Free PMC article.
-
Simeprevir for the treatment of hepatitis C virus infection.Pharmgenomics Pers Med. 2014 Aug 14;7:241-9. doi: 10.2147/PGPM.S52715. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25206310 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources